Tabuk Pharmaceuticals develops, manufactures, markets and distributes branded generic pharmaceuticals and under-licensed products. Established in 1994 in Saudi Arabia, Tabuk Pharmaceuticals’ fast growth has allowed it to become a global company, with a strong focus on the Middle East and North Africa region. Today, it is one of the leading companies in Saudi Arabia ranking third among all pharmaceutical companies, is present in over 25 markets and employs over 2500 employees. Tabuk has a strong R&D pipeline and a complete pharmaceutical portfolio in the MENA region, covering a wide range of therapeutic areas. The company has strengthened its presence by collaborating with multinational companies through vital drugs in-licensing.